Tag: Liver Cirrhosis

By Posted on Posted in Genetic Predisposition, In The Press, Serious Adverse Drug Reaction (sADR), Thasso Post, Theragenomic Medicine Tagged with , , , , , ,

May 16, 2025 – An article on german n-tv  titled “What is liver cirrhosis – and how dangerous is it?” sheds light on the serious condition of liver cirrhosis, particularly illustrated for the general public  in connection with the recent death …

Liver Cirrhosis: How Dangerous Is It? Read more »

By Posted on Posted in New Drug Approval, Thasso Post, Theragenomic Medicine Tagged with , , , , , , ,

June 29, 2016 – The saga goes on: The American  Food & Drug Administration (FDA) just approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) infection both with and without cirrhosis (advanced liver disease). For patients with …

The HCV saga goes on: Epclusa has been approved for treatment of chronic Hepatitis C virus (HCV) infection Read more »